Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice

scientific article published on 5 April 2008

Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/J.1469-0691.2008.01994.X
P698PubMed publication ID18397335
P5875ResearchGate publication ID5456008

P50authorNathan Paul WiederholdQ42104169
John R. GraybillQ109648584
P2093author name stringR Bocanegra
T F Patterson
L K Najvar
C Lambros
N Najarian
P433issue6
P921main subjectcandidiasisQ273510
AminocandinQ4746450
P304page(s)595-600
P577publication date2008-04-05
P1433published inClinical Microbiology and InfectionQ15757285
P1476titleTherapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice
P478volume14

Reverse relations

cites work (P2860)
Q37918556Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations
Q41990022Caspofungin dose escalation for invasive candidiasis due to resistant Candida albicans.
Q37718385Echinocandin pharmacodynamics: review and clinical implications.
Q37358668Effect of Antifungal Treatment in a Diet-Based Murine Model of Disseminated Candidiasis Acquired via the Gastrointestinal Tract.
Q91865119Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis
Q26828993Emerging drugs and vaccines for candidemia
Q37291442Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility
Q52588345Host defense mechanisms in invasive candidiasis originating in the GI tract.
Q37557700Human fungal pathogen Candida albicans in the postgenomic era: an overview.
Q44855715Newer antifungal agents
Q47410811Oral glucan synthase inhibitor SCY-078 is effective in an experimental murine model of invasive candidiasis caused by WT and echinocandin-resistant Candida glabrata
Q27025299Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications
Q35105818The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicans.

Search more.